Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating bone-marrow-derived and placenta-derived multipotent mesenchymal stem/stromal cells for knee osteoarthritis; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bone-marrow-derived mesenchymal stem/stromal cells (bone-marrow-derived mesenchymal stem/stromal cells)
  • placenta-derived mesenchymal stem/stromal cells (placenta-derived mesenchymal stem/stromal cells)

Snippet

Sponsor: Institute of Cell Therapy | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN